Article Information
History
- July 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nurun Fancy1,2,9,
- Nanet Willumsen1,2,9,
- Stergios Tsartsalis2,3,
- Combiz Khozoie1,2,
- Aisling McGarry1,2,4,
- Robert C Muirhead1,2,
- Eleonore Schneegans1,2,
- Karen Davey1,2,5,
- Vicky MN Chau1,2,
- Amy M Smith1,2,6,
- William Scotton7,
- John Hardy7,
- Dann Huh8,
- Paul M Matthews1,2,# and
- Johanna S Jackson1,2,#,*
- 1UK Dementia Research Institute at Imperial College, UK
- 2Department of Brain Sciences, Imperial College London, UK
- 3Department of Psychiatry, University of Geneva, Switzerland
- 4Faculty of Life Science and Medicine, School of Immunology & Microbial Sciences, King’s College London, UK
- 5The Francis Crick Institute, UK
- 6Department of Pharmacology and Clinical Pharmacology and Centre for Brain Research, University of Auckland, New Zealand
- 7Department of Neurodegenerative Disease, University College London (UCL) Institute of Neurology, UK
- 8Translational Biology, Research and Development, Biogen Inc., Cambridge, MA, USA
- ↵*Corresponding author; email: johanna.jackson{at}imperial.ac.uk
↵9 These authors contributed equally
Posted July 13, 2022.
Mechanisms contributing to differential genetic risks for TREM2 R47H and R62H variants in Alzheimer’s Disease
